Patient Partners and 11 Patient Organizations Have Joined CATALIS Québec CATALIS Québec and its partners want the patient’s voice to be heard in all facets of clinical research in Quebec. As a result, we are now working with patient organizations and patient partners from various therapeutic fields by including them on our new patient advisory committee. In carrying out
Me Jean Groleau Named Vice-President of the Board of Directors CATALIS Quebec is pleased to announce that Me Jean Groleau has been named Vice-President of its board of directors. Me Groleau is an experienced administrative and judicial tax litigation lawyer. He began his career in the Ministère du Revenu du Québec’s litigation department. He was then named partner at a
CATALIS is recruiting a Coordinator, Clinical Research Support Service SUMMARY OF THE POSITION Under the authority of the Director of public and patient engagement, the Coordinator, Clinical Research Support Service participates in the development, planning and implementation of the personalized support service in clinical research . As the service coordinator, the incumbent will be an important point of contact
CATALIS Begins Its Public And Patient Engagement Process Since last summer, CATALIS has been developing a patient component that will also complement the comprehensive, collaborative model that defines the organization’s mission. This model already has a wide range of life sciences industry stakeholders, such as the Ministry of Economy and Innovation, the Ministry of Health and Social Services, CATALIS network
The CATALIS Public-Private Network has developed a new FAST TRACK evaluation service that will eventually allow industry-funded clinical trials to be authorized in less than 8 weeks.
CATALIS is hiring! We are looking for a professional in communications inspired to develop promotional campaigns to inform the clinical research network. Under the authority of the CEO, the Senior Communications Advisor will participate in the development, implementation and monitoring of the organization’s communications and marketing activities. MAIN RESPONSIBILITIES • Develop, implement and monitor the organization’s communication and marketing activities:
CATALIS is launching a new call for applications to select public institutions that will receive 2 years of funding for their participation in CATALIS activities. Within the call for applications, public institutions that are members of the Table nationale des directeurs de recherche (TNDR) are invited to apply on 2 levels of clinical research activities: the implementation of automated tools
CATALIS is now implementing its new strategic plan with the creation of new advisory committees Since 2018, CATALIS’s operational activities have been guided essentially by an advisory committee composed of research centre administrators, pharmaceutical industry members, and government representatives. In 2021, given that the new strategic plan extends the scope of CATALIS’s actions, two new advisory committees will be created: a
CATALIS has great plans for the coming year. A message from the chairman of the CATALIS board of directors, Dr. Marc Rivière There is no doubt that this past year has been disconcerting and most unusual. Clinical research was confronted with substantial challenges that highlighted our system’s ability to adapt quickly and find innovative solutions. This exceptional situation caused us to
The Quebec Government’s 2020–2021 budget, tabled yesterday by Minister of Finance Éric Girard, mentions investments in the field of clinical research, a commitment that was favourably received by CATALIS Québec’s board of directors.
2020 promises to be a pivotal year for the rise of clinical research in Quebec. With our partners and sector stakeholders, we are taking concrete steps towards making Quebec an authority in the clinical trial sector.
CATALIS Québec launches a promotional campaign to demonstrate Quebec’s expertise in the conduct of early-phase clinical trials and to encourage new partnerships between the biopharmaceutical industry and university research centres.
According to patient and caregiver associations, patients and the public at large should be better informed about clinical trials. Danika Laberge, general manager of CATALIS Québec, brought this subject up for discussion during the annual Innovative Medicines Canada conference on June 18th.
How to propel Quebec to global leadership in early clinical research? Dr. Marc Rivière, the new chair of the board of directors of CATALIS Quebec, shares his vision.
Successful start for CATALIS: initiative gains momentum, strengthening interest in the life sciences ecosystem MONTRÉAL (Quebec), October 25, 2017 —CATALIS presented its five-year plan to their partners’ that will set in motion the initiative announced in the Quebec government’s 2017-2027 Québec Life Sciences Strategy. The mission of CATALIS Quebec Clinical Trials, formerly known as the Early Stage Clinical Trials (ESCT) initiative,
During the recent BIO International Convention, Gaétan Barrette, Minister of Health and Social Services, announced that the Québec government will be contributing $5.3 million to the early clinical research initiative